zonisamide (Cipla USA Inc.)
Welcome to the PulseAid listing for the zonisamide drug offered from Cipla USA Inc.. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Sulfonamides [Chemical/Ingredient],Carbonic Anhydrase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cipla USA Inc. |
| NON-PROPRIETARY NAME: | zonisamide |
| SUBSTANCE NAME: | ZONISAMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Sulfonamides [Chemical/Ingredient],Carbonic Anhydrase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-07-13 |
| END MARKETING DATE: | 0000-00-00 |
zonisamide HUMAN PRESCRIPTION DRUG Details:
| Item Description | zonisamide from Cipla USA Inc. |
| LABELER NAME: | Cipla USA Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2016-07-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69097-861_2e6a08d2-d909-4059-ae2f-6991e9cb9ee1 |
| PRODUCT NDC: | 69097-861 |
| APPLICATION NUMBER: | ANDA077869 |
Other ZONISAMIDE Pharmaceutical Manufacturers / Labelers:
